PFG Advisors’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-3,469
| Closed | -$200K | – | 539 |
|
|
2022
Q2 | $200K | Sell |
3,469
-38
| -1% | -$2.19K | 0.02% | 369 |
|
|
2022
Q1 | $218K | Sell |
3,507
-19,412
| -85% | -$1.21M | 0.02% | 383 |
|
|
2021
Q4 | $1.63M | Sell |
22,919
-8,828
| -28% | -$629K | 0.16% | 181 |
|
|
2021
Q3 | $2.38M | Sell |
31,747
-80
| -0.3% | -$5.99K | 0.26% | 109 |
|
|
2021
Q2 | $2.46M | Buy |
31,827
+920
| +3% | +$71.1K | 0.28% | 99 |
|
|
2021
Q1 | $2.28M | Buy |
30,907
+440
| +1% | +$32.5K | 0.29% | 99 |
|
|
2020
Q4 | $2.14M | Buy |
30,467
+100
| +0.3% | +$7.01K | 0.36% | 74 |
|
|
2020
Q3 | $1.83M | Buy |
30,367
+147
| +0.5% | +$8.86K | 0.35% | 79 |
|
|
2020
Q2 | $1.81M | Buy |
30,220
+140
| +0.5% | +$8.39K | 0.41% | 76 |
|
|
2020
Q1 | $1.59M | Sell |
30,080
-90
| -0.3% | -$4.76K | 0.43% | 75 |
|
|
2019
Q4 | $1.66M | Sell |
30,170
-225
| -0.7% | -$12.4K | 0.41% | 77 |
|
|
2019
Q3 | $1.41M | Buy |
30,395
+3
| +0% | +$139 | 0.39% | 72 |
|
|
2019
Q2 | $1.6M | Buy |
30,392
+232
| +0.8% | +$12.2K | 0.43% | 61 |
|
|
2019
Q1 | $1.57M | Sell |
30,160
-795
| -3% | -$41.5K | 0.48% | 55 |
|
|
2018
Q4 | $1.6M | Buy |
+30,955
| New | +$1.6M | 0.5% | 56 |
|